SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to announce their partnership with Lunit, a global leader in AI-driven cancer diagnostics and therapeutics, to bring a new era of AI-powered breast cancer detection to patients across the country. The partnership marks a major milestone in SimonMed’s mission to save lives through early detection.
SimonMed has selected Lunit INSIGHT DBT™, in combination with Volpara Analytics™, as the most advanced AI solution for breast cancer screening after an extensive evaluation of technologies on the market. This best-in-class software will now power SimonMed’s Personalized Breast Cancer Detection (PBCD) service, designed to provide every patient with a precise, highly personalized, and data-driven screening experience.
“This is more than just an upgrade—it’s an important step forward for our patient’s health,” said Dr. Sean Raj, Chief Innovation Officer at SimonMed Imaging and Fellow of The Society of Breast Imaging (FSBI) “We’ve evaluated a range of AI technologies, and Lunit’s performance, speed, and clinical validation stood above the rest. This partnership enables us to offer the most precise and personalized mammogram experience to date—and when paired with our board-certified breast radiologists, we believe it offers the most advanced mammogram available today”
Also Read: Russ Johannesson Named CEO of Caregentic to Drive Growth
Lunit INSIGHT DBT is trained on millions of images and engineered to detect even the most subtle signs of breast cancer, improving both sensitivity and specificity. Integrated into SimonMed’s national network of over 170 accredited centers and supported by more than 200 subspecialty-trained radiologists, this AI solution helps ensure earlier detection, faster turnaround times, and actionable insights for patients.
“This is the most advanced AI solution we’ve ever adopted,” said Dr. John Simon, MD, Founder and CEO of SimonMed Imaging. “It reflects our unwavering commitment to providing every patient we see with the most accurate, affordable, and proactive care possible.”
“SimonMed is leading by example,” said Craig Hadfield, CEO of Volpara Health, a Lunit company bringing innovative AI solutions to the United States. “This is more than a technology upgrade—it’s a transformation of care. With Volpara and Lunit, SimonMed is helping set a new standard for what modern high-quality breast screening should look like: data-driven, patient-focused, and grounded in clinical excellence.”
Source: PRNewswire
